Anupam Rasayan India Ltd approves Q2 FY27 results, with consolidated revenue of ₹805.9 crore and net profit of ₹65.0 crore
- Consolidated revenue rose 10.2% YoY and 23.0% QoQ; net profit increased 13.7% YoY and 26.9% QoQ.
- Standalone revenue was ₹397.2 crore and net profit was ₹45.7 crore.
- Consolidated results include Bliss GVS Pharma from its acquisition date, September 28, 2026; auditor’s limited-review conclusions were unmodified.
